Latest updates for Biotech Startup

Fresh curated links around biotech startup are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Prime Venture, Leo Capital back biotech startup StrainX in $13M round
  • This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’
  • Meet LiteFold, a biotech startup using proprietary AI to speed up drug discovery

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

yourstory.com /5 days ago

Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.

Read source
medcitynews.com /1 week ago

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Read source
yourstory.com /2 weeks ago

Meet LiteFold, a biotech startup using proprietary AI to speed up drug discovery

Bengaluru and Delaware-based LiteFold is a biotech AI-native platform designed to accelerate computational biology workflows.

Read source
medcitynews.com /2 weeks ago

This TechBio Startup Just Raised $2B Without Disclosing a Single Detail About Its Drugs

Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs. The post This...

Read source
techcrunch.com /1 month ago

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

Read source
yourstory.com /3 weeks ago

C-CAMP launches 9th edition of national bio entrepreneurship competition with Rs 20 cr at stake

India’s largest biotech startup competition returns with Rs 20 crore prize pool, widening push to back science-led innovation beyond metro hubs.

Read source
news.mit.edu /1 month ago

Bringing AI-driven protein-design tools to biologists everywhere

Founded by Tristan Bepler PhD ’20 and former MIT professor Tim Lu PhD ’07, OpenProtein.AI offers researchers open-source models and other tools for protein engineering.

Read source
fiercebiotech.com /1 month ago

Alamar Biosciences files for IPO amid opening life sciences funding window

Californian protein sequencing company Alamar Biosciences is seeking an IPO worth up to $159 million amid a growing boom in life sciences public offerings.

Read source
thenextweb.com /1 month ago

Helical closes $10M seed to turn bio foundation models into systems

The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by re...

Read source
thestartupmag.com /1 month ago

4 Mistakes Biotech Startups Make — And How to Avoid Them

It’s no secret that finding success in the biotech industry can be extraordinarily challenging. With long timeframes (the discovery to The post 4 Mistakes Biotech Startups Make — A...

Read source
thenextweb.com /1 month ago

Anthropic just paid $400 million for a startup with fewer than 10 people

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a te...

Read source
fiercebiotech.com /3 weeks ago

Banyan BioInnovations puts down roots with $100M, Icon partnership

Banyan BioInnovations is debuting with more than $100 million aimed at developing NewCos around promising clinical assets, plus a partnership with global contract research organiza...

Read source
techcrunch.com /1 month ago

Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer.

Read source
fiercebiotech.com /1 week ago

With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate

In the sprawling metropolis of Houston, a new biotech has emerged to tackle the biology underlying a lung disease that has no clear cause. Oorja Bio launched yesterday afternoon wi...

Read source
biopharmadive.com /1 week ago

After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets

Parabilis is teeing up the latest high-profile stock issuance in a year when biotech IPOs are averaging more than $286 million in total proceeds.

Read source
techcrunch.com /3 days ago

Triomics nabs $22M to bring oncology-specific AI to cancer centers

The Series B round was led by Battery Ventures.

Read source
fiercebiotech.com /2 weeks ago

Quantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.

Read source
labiotech.eu /1 month ago

The biggest biotech funding rounds in March 2026

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in March 2026. The post The biggest biotech funding round...

Read source
thenextweb.com /1 month ago

Generare raises €20M to decode the 97% of microbial chemistry

The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecule...

Read source
biopharmadive.com /1 week ago

Oorja, run by Acceleron veterans, launches to make new fibrosis drugs

The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.

Read source
techcrunch.com /1 week ago

This young startup is taking on a fragrance industry that hasn’t changed in almost half a century

Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures. 

Read source
seekingalpha.com /1 month ago

Anthropic scoops up biotech startup Coefficient Bio for $400M: report

Read source
biopharmadive.com /1 month ago

Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to...

Read source
fiercebiotech.com /1 month ago

Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS

The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 million series A.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Biotech Startup

news.mit.edu

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

thestartupmag.com

Recent coverage from public sources
Public source